FABP4 and ovarian cancer: The inhibition of FABP4 by CRISPR and siRNA reduced the capacity of adipocyte cocultured ovarian cancer cells to accumulated lipids, and with the impact of this, adipocyte‐relevant β‐oxidation, ROS generation and lipid peroxidation were affected.